Introduction
Domperidone, [5-chloro-1-{1-[3-(2-oxobenzimidazolin-1-yl)-propyl]-4-piperidyl}benzimidazolin-2-one] is a white, or almost white, powder. Practically insoluble in water, slightly soluble in alcohol and methyl alcohol, it is soluble in dimethylformamide. 1 It is used as an anti-emetic and to control gastrointestinal effects of dopaminergic drugs in the management of Parkinsonism. It may also be used in those patients who experience peripheral effects with levodopa. 2 Several methods have been reported for domperidone determination, including spectrophotometric [3] [4] [5] and highperformance liquid chromatography (HPLC). [6] [7] [8] [9] [10] [11] The BP 1998 reported a titrimetric method using 0.1 M perchloric acid as a titrant and benzein as an indicator. 12 This titrimetric procedure requires about 0.25 g to provide accurate results.
No spectrophotometric work has been done since 1998.
Metoclopramide hydrochloride, [4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide hydrochloride] is a white, or almost white, crystalline powder, is odourless, and 1.0 g is soluble at 25˚C in 0.7 ml of water, 3.0 g of ethanol (96%), and 55 g of chloroform, though it is practically insoluble in ether. It is soluble in dilute hydrochloric acid. It shows two ionization constants; pK1 = 0.42 and pK2 = 9.71. 13 It is used as an anti-emetic in the treatment of some forms of nausea and vomiting and to increase gastrointestinal motility. It is of little benefit in the prevention or treatment of motion sickness or in the treatment of nausea and vertigo due to Meniere disease or other labyrinth disturbance. 14 Many analytical methods have been developed for the analysis of metoclopramide, most based on spectrophotometric, [15] [16] [17] [18] [19] [20] [21] [22] [23] fluorometric, 24 1 H-NMR spectroscopic, 25 or chromatographic techniques. [26] [27] [28] [29] The British Pharmacopoeia 1998 reported a potentiometric method using 0.1 M perchloric acid for the determination of metoclopramide HCl powder and a UV method for tablets and ampoules. 30 The potentiometric method requires about 250 mg of drug, whereas the UV method is liable to interferences from tablet excipients, and requires pre-extraction with chloroform. Yet, no work has been performed to use a redox reaction for the determination of domperidone (I) and metoclopramide (II). The purpose of the present study was to apply redox reactions to develop simple, accurate, sensitive and reproducible methods of analysis. This work describes spectrophotometric methods that can be used in laboratories where modern and expensive apparatus, such as that required for GLC, TLC, or HPLC, is not available.
Experimental

Apparatus
All absorption spectra were made using a JASCO 530V (UVVis) spectrophotometer (Japan) with a scanning speed of 400 nm/min and a band width of 2.0 nm, equipped with 10 mm matched quartz cells. An Orion research Model 601A/digital ionalyzer pH meter (Japan) was used for checking the pH values of a buffer solution prepared as previously recommended. 31 
Reagents
All of the chemicals used were of analytical grade, and all of the solutions were freshly prepared in doubly distilled water. An aqueous solution of Chromotrope 2R (Aldrich product), 5 × 10 -3 M, and Rhodamine 6G (BDH) 1 × 10 -3 M were prepared by dissolving an accurate weight of dye in the least amount of water and completed to the mark in a 100 ml calibrated flask with water.
A solution of cerium(IV) sulfate (May and Baker) 3 × 10 -3 M was prepared by dissolving a known weight of Ce(SO4)2 in the least amount of warm 1.0 M sulfuric acid in a 100 ml calibrated flask, and then diluted with the same acid to the mark.
Acetate buffer solutions of pH values 2.56 -5.60 were prepared as recommended previously. 33 Domperidone and metoclopramide stock solutions (1.0 mg ml -1 ) were prepared by dissolving 100 mg of pure material in 20 ml of water, and completed to 100 ml with water in a 100 ml calibrated flask. Working solutions were obtained by further dilution of the stock solutions with water.
General procedure Methods A and B. A 0.1 -2.90 ml portion of 20 µg ml -1 of the drug I or II solution for method A and 0.1 -2.75 ml of 20 µg ml -1 for method B were transferred into a series of 10 ml calibrated flasks. Solutions of 1.0 ml Fe 3+ -o-phen or Fe 3+ -bipy reagent and 4.0 ml acetate buffer solution of pH 4.4 and 4.6 using methods A and B, respectively, were added and heated on a water bath at 80˚C for 10 min. The mixture was cooled to room temperature and the volume was made up to the mark with water. The developed colored complexes formed were measured at 510 and 522 nm using methods A and B, respectively, against a reagent blank treated similarly. Methods C and D. An aliquot of drug I and II containing 1.0 to 44 µg was added to an excess volume (1.0 ml) of 3 × 10 -3 M Ce 4+ containing 1.0 ml of 1.0 M H2SO4. The solution mixture was boiled in a water bath for 5.0 min, and cooled; then, 2.0 ml of 1 × 10 -3 M C2R was added for method C, whereas 0.5 ml of 1 × 10 -3 M of Rh6G was added to a hot solution for method D. After the volume was completed to 10 ml with water, a decrease in the color intensities of C2R or Rh6G were measured spectrophotometrically at their corresponding maximum wavelengths of 528 or 525 nm, respectively. The concentration range was determined in each case by plotting the concentrations of drug I or II against the absorbance at the corresponding λmax.
Procedure for dosage forms For tablets. At least ten tablets of the drug were weighed into a small dish, powdered and mixed well. A portion equivalent to 100 mg was weighed and dissolved in 100 ml of water, shaken well and filtered through a sintered glass crucible (G4). A 1.0 ml aliquot of the test solution was diluted to 100 ml in a calibrated flask. An aliquot of the diluted drug solution was then treated as described above in procedures A -D.
For injection.
The contents of five ampoules were quantitatively transferred into 250 ml calibrated flasks and completed to the mark with water. The above-stated procedures (A -D) were applied to determine the examined drug.
Results and Discussion
Methods A and B 1,10-Phenanthroline and 2,2′-bipyridyl are organic bases with similar chemical structures and contain the iron(II) specific group. 34 Methods A and B are based on the formation of tris(ophenanthroline) or tris(2,2′-bipyridyl) iron(II) chelate upon the reaction of drugs I and II with the Fe 3+ -phen or Fe 3+ -bipy reagent. The reaction proceeds through the reduction of Fe 3+ to Fe 2+ and the subsequent formation of an intensive orange-red coloration of the complex. 35, 36 The absorption spectra of the colored species in the proposed methods at the optimum 37 and observing its effect on the absorbance of colored species.
Matrix effects
An acetate buffer solution was the optimal one of those examined (universal, phosphate, thiel, borate and acetate). 33 The optimum pH values were 4.4 and 4.6 for methods A and B, respectively. Moreover, 4.0 ml of a buffer solution was sufficient for complete color development.
The addition of 1.0 ml of the reagent solution was sufficient to obtain the maximum and reproducible absorbance for 4.0 µg ml -1 of studied drug (Fig. 1) . Smaller amounts gave incomplete complex formation, whereas a larger concentration had no effect on complex formation, although the absorbance increased slightly due to the background of the reagent used.
The reaction to complete color formation proceeded very slowly at room temperature. To accelerate it, a higher temperature was employed, and the maximum absorbance was obtained after heating for about 10 min on a water bath at 90˚C. Further heating caused no appreciable change in the color. The color formed was very stable for more than 24 h.
Methods C and D
Methods C and D involved two stages: (1) Oxidation of the drugs I and II with excess Ce 4+ ions in acid medium under the effect of heating. (2) Determination of the unreacted oxidant by measurement of the decrease in absorbance of C2R or Rh6G at a suitable λmax of 528 or 525 nm for method C or D, respectively. The decrease in the color intensity is attributed to the oxidation of the dye to its degredate products, and thus the absorbance decreased.
Matrix effect
The most suitable acid to be used with Ce 4+ was found to be sulfuric acid of 1.0 M, if present as 1.0 ml on the total volume (10 ml) of the reaction mixture.
Sample solutions containing drug I or II, Ce 4+ and H2SO4 were heated at different temperatures ranging from 30 to 100˚C. The obtained results indicated that the reaction is catalyzed by heat, and is maximum at 100˚C. The time required to complete the reaction is 5.0 min.
In method C, the solution must be cooled for at least for 3.0 min before the addition of C2R, whereas in method D, the addition of Rh6G to a hot solution gives the maximum absorbance, and thus there is no need to cool the solution before adding the dye.
To establish the optimum concentration of the reagent, different volumes of 1 × 10 -3 M C2R or Rh6G solution were used. The optimum volumes used for producing the maximum and reproducible color intensity were 2.0 ml and 0.5 ml for C and D methods, respectively (Fig. 2) .
The color stability for methods A, B, C and D was found to be stable for at least 36, 30, 72 and 48 h, respectively.
Quantification
The Beer-Lambert law limits, molar absorptivity, Sandell sensitivity, regression equations and correlation coefficients 749 ANALYTICAL SCIENCES MAY 2003, VOL. 19 obtained by linear square treatment of the results are given in Table 1 . The detection and quantification limits were calculated from the standard deviation of the absorbance measurements obtained from a series of 13 blank solutions for each procedure. The limit of detection (K = 3.0) and of quantification (K = 10) were established according to the IUPAC definitions. 38 In order to determine the accuracy and precision of the methods, solutions containing four different concentrations of drug I or II were prepared and analyzed in six replicates. The analytical results obtained from this investigation are summarized in Table  2 . The percentage standard deviation (≤ 1.56%) and the percentage range of the error at 95% confidence level (≤ ± 1.84%) can be considered to be satisfactory. The performances of the methods were assessed by calculating the t-and F-values compared with the official methods. 12, 30 The mean values were obtained in a Student's tand F-tests at the 95% confidence limits for five degrees of freedom. 39 The results showed that the calculated t-and F-values did not exceed the theoretical ones.
Interference
To test the efficiency and selectivity of the proposed analytical methods (A -D) to pharmaceutical formulations, a systematic study under the optimum experimental conditions was made for the effect of additives and excipients (e.g. lactose, glucose, fructose, calcium hydrogen phosphate, magnesium stearate and starch) that are usually present in dosage forms. The criterion of interference was an error of not more than ± 3.0% in the absorbance. In this study, a wide range of concentrations was used in which the determination of the 4.0 mg level of a drug was performed. Experimentals showed that there was no interference from additives or excipients for the examined methods (A -D) up to 200-fold excess. Also, there was no interference from common degradation product results from thermal and hydrolytic degradation.
Analytical applications
The proposed methods were successfully applied to determine drugs I and II in their pharmaceutical preparations. The obtained results were compared statistically by a Student's t-test for accuracy, and a variance ratio F-test for precision with the official method 12, 30 (depending on titrimetric and potentiometric titrations using 0.1 M perchloric acid) at the 95% confidence level with five degrees of freedom, as recorded in Table 3 . The results showed that the t-and F-values were less than the critical value, indicating that there was no significant difference between the proposed and official methods. Because the proposed methods were more reproducible with high recoveries than the official method, they can be recommended for the routine analysis in the majority of drug quality control laboratories.
Conclusions
The proposed methods are simpler, less time consuming and more sensitive than the official methods 11, 30 (based on titrimetric and potentiometric titrations using 0.1 M perchloric acid). Although the color development for methods A and B at room temperature required 2.0 h for completion, this can be shortened to 10 min by raising the temperature to 90˚C. All of the proposed methods were advantageous over other reported visible spectrophotometric methods with respect to their higher sensitivity, which permits the determination of up to 0.2 µg ml -1 . Simplicity, reproducibility, precision, accuracy and stability of the colored species for ≥ 24 h are noted advantages. No interference from associated excipients, additives and degradate products was observed. The proposed methods can be applied for routine analysis and in quality control laboratories for the quantitative determination of studied drugs in raw materials and in pharmaceutical formulations, depending upon the availability of the chemicals and the nature of other excipients present in the sample. 
